Free Trial

Tandem Diabetes Care (TNDM) News Today

$53.43
+1.68 (+3.25%)
(As of 05/30/2024 ET)
Redburn Atlantic Begins Coverage on Tandem Diabetes Care (NASDAQ:TNDM)
Redburn Atlantic started coverage on Tandem Diabetes Care in a research report on Thursday. They set a "buy" rating and a $60.00 target price for the company.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Expected to Post Q2 2024 Earnings of ($0.53) Per Share
Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) - Equities researchers at Leerink Partnrs cut their Q2 2024 earnings per share (EPS) estimates for Tandem Diabetes Care in a report released on Tuesday, May 28th. Leerink Partnrs analyst M. Kratky now forecasts that the medical device company
Charles Schwab Investment Management Inc. Buys 29,730 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Charles Schwab Investment Management Inc. boosted its stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 8.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 396,741 shares of the medical dev
Tandem Diabetes Care (NASDAQ:TNDM) Sets New 52-Week High at $53.00
Tandem Diabetes Care (NASDAQ:TNDM) Reaches New 1-Year High at $53.00
Victory Capital Management Inc. Has $399,000 Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Victory Capital Management Inc. lowered its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 86.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,484 shares of the medical device company's stock after sell
Trexquant Investment LP Boosts Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Trexquant Investment LP lifted its stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 159.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 161,954 shares of the medical device company's stock
Citigroup Upgrades Tandem Diabetes Care (NASDAQ:TNDM) to Buy
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $75.00 by Analysts at Lake Street Capital
Lake Street Capital upped their price objective on Tandem Diabetes Care from $60.00 to $75.00 and gave the company a "buy" rating in a research note on Wednesday.
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up Following Analyst Upgrade
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up Following Analyst Upgrade
Tandem Diabetes Care (NASDAQ:TNDM) Rating Increased to Buy at Citigroup
Citigroup upgraded Tandem Diabetes Care from a "neutral" rating to a "buy" rating and upped their target price for the company from $40.00 to $57.00 in a research report on Wednesday.
GW&K Investment Management LLC Buys Shares of 1,226,758 Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
GW&K Investment Management LLC bought a new stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,226,758 shares of the medical device co
Tandem Diabetes Care (NASDAQ:TNDM) Reaches New 12-Month High at $52.51
Tandem Diabetes Care (NASDAQ:TNDM) Hits New 52-Week High at $52.51
Tandem Diabetes Care Sees Unusually High Options Volume (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Traders acquired 6,339 call options on the stock. This represents an increase of approximately 620% compared to the average daily volume of 880 call options.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Position Lessened by Paradice Investment Management LLC
Paradice Investment Management LLC cut its stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 28.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,081,886 shares of the medical
Natixis Advisors L.P. Purchases Shares of 34,681 Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Natixis Advisors L.P. acquired a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,681 shares of the medica
M&T Bank Corp Purchases 26,943 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
M&T Bank Corp raised its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 118.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 49,649 shares of the medical device company's stock after ac
Truist Financial Corp Takes $2.59 Million Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Truist Financial Corp acquired a new stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 87,484 shares of the medical device company's stock, valued at approximately $2,588,000. Truist Financi
Russell Investments Group Ltd. Purchases 109,505 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Russell Investments Group Ltd. increased its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 79.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 247,325 shares of the medical device
Lisanti Capital Growth LLC Invests $3.13 Million in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Lisanti Capital Growth LLC purchased a new position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 105,895 shares o
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $55.00 by Analysts at Barclays
Barclays lifted their target price on shares of Tandem Diabetes Care from $39.00 to $55.00 and gave the company an "overweight" rating in a research note on Monday.
Tandem Diabetes Care (NASDAQ:TNDM) Sets New 12-Month High After Analyst Upgrade
Tandem Diabetes Care (NASDAQ:TNDM) Hits New 12-Month High Following Analyst Upgrade
Tandem Diabetes Care (NASDAQ:TNDM) Earns "Overweight" Rating from Piper Sandler
Piper Sandler reiterated an "overweight" rating and set a $50.00 price target (up previously from $35.00) on shares of Tandem Diabetes Care in a report on Friday.
Tandem Diabetes Care (NASDAQ:TNDM) PT Raised to $36.00
Robert W. Baird increased their price objective on shares of Tandem Diabetes Care from $28.00 to $36.00 and gave the stock a "neutral" rating in a report on Friday.
Q1 2024 Tandem Diabetes Care Inc Earnings Call
Get Tandem Diabetes Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

TNDM Media Mentions By Week

TNDM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TNDM
News Sentiment

1.14

0.82

Average
Medical
News Sentiment

TNDM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TNDM Articles
This Week

13

5

TNDM Articles
Average Week

Get Tandem Diabetes Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TNDM) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners